Artificial Intelligence in Pharmacovigilance and COVID-19.

导出原文传递

翻译打印收藏纠错

第一作者： Kamini,Bhardwaj

第一单位： Raj Kumar Goel Institute of Technology (Pharmacy), 5-Km. Stone, Delhi-Meerut Road, Ghaziabad, Uttar Pradesh, India.

作者： Kamini,Bhardwaj ^[1] ; Rabnoor,Alam ^[1] ; Ajay,Pandeya ^[2] ; Pankaj Kumar,Sharma ^[1]

作者单位： Raj Kumar Goel Institute of Technology (Pharmacy), 5-Km. Stone, Delhi-Meerut Road, Ghaziabad, Uttar Pradesh, India. ^[1] Graphic Era University, Bellroad, Clement Town, Dehradun, Uttarakhand, India. ^[2]

关键词 Adverse drug reaction (ADR)National Pharmacovigilance Program (NPP)Spontaneous Reporting System (SRS)Uppsala Monitoring Centre (UMC)World health organization (WHO)artificial intelligence (AI)pharmacovigilance (PV)

主题词女(雌)性(Female);人类(Humans);青少年(Adolescent);药物副反应报告系统(Adverse Drug Reaction Reporting Systems);人工智能(Artificial Intelligence);贝叶斯定理(Bayes Theorem)

DOI 10.2174/1574886317666220405115548

PMID 35382726

发布时间 2023-02-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Current drug safety

2023年18卷1期

5-14页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Artificial Intelligence in Pharmacovigilance and COVID-19.

Current drug safety

相似文献

Current drug safety

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Artificial Intelligence in Pharmacovigilance and COVID-19.

Current drug safety

相似文献

Current drug safety

相关期刊

检索历史清除